| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 66.46B | 63.52B | 56.59B | 50.62B | 48.68B |
| Gross Profit | 22.09B | 14.50B | 7.17B | 5.68B | 12.03B |
| EBITDA | 13.93B | 6.72B | 735.00M | -648.00M | 7.88B |
| Net Income | 10.28B | 4.67B | -188.00M | -1.29B | 1.61B |
Balance Sheet | |||||
| Total Assets | 119.76B | 111.62B | 103.36B | 97.99B | 99.44B |
| Cash, Cash Equivalents and Short-Term Investments | 678.00M | 5.24B | 5.87B | 4.91B | 4.77B |
| Total Debt | 7.49B | 8.09B | 7.94B | 7.96B | 7.98B |
| Total Liabilities | 89.17B | 90.25B | 85.73B | 80.63B | 74.31B |
| Stockholders Equity | 30.61B | 21.44B | 17.77B | 17.49B | 25.18B |
Cash Flow | |||||
| Free Cash Flow | 9.88B | 8.72B | 3.96B | 4.70B | 4.77B |
| Operating Cash Flow | 10.11B | 8.93B | 4.23B | 5.12B | 5.12B |
| Investing Cash Flow | -7.25B | -8.25B | -3.00B | -1.73B | 510.00M |
| Financing Cash Flow | -2.88B | -697.00M | -1.24B | -3.42B | -5.24B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $54.80B | 5.50 | 39.51% | 1.91% | 7.07% | 100.42% | |
80 Outperform | $129.59B | 12.82 | 14.97% | 1.22% | 6.68% | -1.78% | |
79 Outperform | $39.36B | 10.61 | 21.66% | 1.55% | 7.11% | 22.52% | |
76 Outperform | $25.47B | 10.76 | 16.04% | 2.10% | -0.63% | -30.68% | |
76 Outperform | $119.20B | 10.57 | ― | 2.20% | 18.35% | 32.36% | |
76 Outperform | $64.54B | 10.88 | 20.70% | 1.49% | 6.75% | 30.83% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
Allstate disclosed that its January 2026 monthly update on estimated catastrophe losses and policies in force has been made available on its investor website for market participants. The information, furnished rather than filed as part of a regulatory report, provides investors with additional transparency into Allstate’s recent catastrophe experience and current policy base, which are key drivers of its financial performance and risk profile.
The most recent analyst rating on (ALL) stock is a Hold with a $215.00 price target. To see the full list of analyst forecasts on Allstate stock, see the ALL Stock Forecast page.
In December 2025, Allstate published its monthly release detailing estimated catastrophe losses and policies in force, making the information available on its investor website. The disclosure, provided as an exhibit to a regulatory filing, supplied investors and other stakeholders with updated metrics on the company’s exposure to catastrophic events and its current insurance portfolio, supporting ongoing assessment of Allstate’s financial performance and risk profile.
The most recent analyst rating on (ALL) stock is a Buy with a $255.00 price target. To see the full list of analyst forecasts on Allstate stock, see the ALL Stock Forecast page.
Allstate announced that its November 2025 monthly update detailing estimated catastrophe losses and policies in force has been made available to investors via its website. The release signals the company’s ongoing practice of providing regular transparency on catastrophe exposure and policy trends, information that is closely watched by investors and other stakeholders assessing Allstate’s risk profile and operating performance.
The most recent analyst rating on (ALL) stock is a Buy with a $254.00 price target. To see the full list of analyst forecasts on Allstate stock, see the ALL Stock Forecast page.